30,000 to 40,000 doses of NeJa Rab vaccine is being produced annually which is not sufficient to meet the national demand of rabies vaccine. Therefore, the annual target of the tissue culture anti-rabies vaccine for animal use has to be increased. At the same time the laboratory is also going to start commercial production of tissue culture anti-rabies vaccine for human use in near future. Keeping in view of these facts the human resource, laboratory facility and the technical capability of the laboratory should also be increased accordingly.